VHL — Vitasora Health Cashflow Statement
0.000.00%
- AU$42.58m
- AU$42.24m
- AU$3.71m
Annual cashflow statement for Vitasora Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 1.17 | 0.525 | 0.592 | 0.585 | 0.62 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.34 | -8.48 | -4.49 | -6.64 | -9.17 |
Capital Expenditures | -0.054 | -0.002 | -0.022 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | -1.89 | 1.13 |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.054 | -0.002 | -0.022 | -1.89 | 1.13 |
Financing Cash Flow Items | -0.547 | -0.033 | -0.391 | -0.56 | -0.257 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 11.8 | 1.64 | 3.46 | 9.13 | 7.66 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.42 | -6.76 | -1.07 | 0.617 | -0.369 |